U.S. Food and Drug Administration Approves BioMarin's PALYNZIQ® (pegvaliase-pqpz) for Adolescents 12 Years of Age and Older with Phenylketonuria (PKU) ...Middle East

Treatment with PALYNZIQ led to statistically significant blood phenylalanine (Phe) lowering compared to diet alone in pivotal Phase 3 PEGASUS study PALYNZIQ is the only enzyme substitution therapy approved for the treatment of people with PKU SAN RAFAEL, Calif., Feb. 27, 2026 /PRNewswire/...

Hence then, the article about u s food and drug administration approves biomarin s palynziq pegvaliase pqpz for adolescents 12 years of age and older with phenylketonuria pku was published today ( Saturday 28/02/2026 - 04:05 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( U.S. Food and Drug Administration Approves BioMarin's PALYNZIQ® (pegvaliase-pqpz) for Adolescents 12 Years of Age and Older with Phenylketonuria (PKU) )

Also on site :

• KLOS-FM host Uncle Joe Benson, one LA radio’s legendary voices, dies at 76
• Fitness Influencer Lee ‘Malibu’ Markham Admits He Falsely Claimed IED Injury
• OpenAI says Canada mass shooter evaded ban with second ChatGPT account